Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The history now shows recruitment status updated to no longer looking for participants and a new Revision: v3.6.0 added, replacing the previous Revision: v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-12T13:37:30.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 appears in the study record history, and the previous revision v3.5.4 is no longer listed. This change updates the history log metadata for the record.
    Difference
    0.1%
    Check dated 2026-06-05T08:46:37.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.4, was added to the history, replacing the previous tag, v3.5.3. This indicates a version update to the page rendering rather than changes to the study data or text.
    Difference
    0.1%
    Check dated 2026-05-14T23:00:45.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) has been added to the Record History. The previous revision (v3.5.2) has been removed.
    Difference
    0.1%
    Check dated 2026-04-30T18:50:34.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.2 and the v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:07:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T19:19:55.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.